Bilişsel, Otonomik ve Uykusuzluk Bozuklukları Olan COVID-19 Hastalarının Tıbbi Sülük Tedavisi Kullanılarak Rehabilitasyonu

Year 2023, Volume: 4 Issue: 4, 3 - 20, 15.12.2023

Saltanat Serikbayeva Namazbay Ormanov Talgat Ormanov Ibragim Ishigov Murat Zhunussov Gulnaz Kayshibayeva Ferruh Yücel

https://doi.org/10.53445/batd.1277497

Abstract

Yeni coronavirus (COVID-19) hastalığı pandemisi, dünya çapında tarihi ve acil bir sorundur. Hastalığın uzun vadeli sonuçları, tedavi ve önleme açısından daha fazla araştırmaya gereksinim duyan nörolojik bozukluklardır. Geleneksel tıbbın dışında bilişsel, otonomik ve uyku komplikasyonlarının yönetimi tıbbi sülükler kullanılarak rehabilite edilebilir. Bu çalışmanın amacı COVID-19 hastalarının hirudoterapi öncesi ve sonrası nörolojik durumlarını karşılaştırmaktır. Bu kesitsel çalışma Ocak-Aralık 2021 tarihleri arasında Hoca Ahmet Yesevi Uluslararası Türk-Kazak Üniversitesi Tıp Merkezinde gerçekleştirildi. Araştırma populasyonu tıbbi sülük tedavisi (MLT) uygulanan hafif ve şiddetli COVID-19 (6 aydan fazla) formları olan 83 hastadan oluşuyordu. Hastalara 6. ve 11. günlerde MLT uygulandı ve onların kognitif, otonomik ve uyku bozuklukları değerlendirildi. İstatistiksel analizler SPSS İstatistik (Sürüm 20.0, IBM, USA) kullanılarak yapıldı. Çalışmaların sonuçları COVID-19 hastalarında ilerleyici bir nörolojik bozulma olduğunu göstermektedir. Tam bir MLT kürü alan hastalardaki nöropsikolojik gözlemler bilişsel, otonomik ve uyku bozukluklarında nesnel bir iyileşme olduğunu gösterdi. Özellikle, Pittsburgh Uyku Kalitesi İndeksi (PSQI), Uykusuzluk Şiddeti İndeksi (ISI), Montreal Bilişsel Değerlendirme (MoCA) Ölçeği, Schulte Tabloları, Spielberger-Khanin Anksiyete Ölçeği (SKAS), Beck Depresyon Envanteri (BDI), Otonomik bozukluk belirtilerini teşhis etme çalışma şeması, Epworth Uykulu olma Ölçeği (ESS), Uyku Bozuklukları Şiddeti İndexi (ISSD) değerleri MLT uygulamalarından sonra düzeldi.

Keywords

COVID-19, Hirudoterapi, Tıbbi Sülük Tedavisi, Kognitif Bozukluklar, Otonomik Bozukluklar

Rehabilitation of COVID-19 Patients with Cognitive, Autonomic and Insomnia Disorders Using Medicinal Leech Therapy

Abstract

New coronaNew coronavirus disease (COVID-19) pandemic is a historical and urgent issue worldwide. The long-term consequences of the disease are neurological disorders, which need further investigation in terms of treatment and prevention. Apart from the traditional medical approach, management of cognitive, autonomic and sleep complications may be rehabilitated using medicinal leeches. The purpose of this study is to compare the neurological condition of COVID-19 patients before and after hirudotherapy. This cross-sectional study was conducted from January to December 2021 at the medical centre of the Khoja Akhmet Yassawi International Kazakh-Turkish University. The research population consisted of 83 patients with mild and severe forms of COVID-19 (more than 6 months), who underwent medicinal leech therapy (MLT). MLT was applied to the patients on the 6th and 11th days and their assessment of cognitive, autonomic and sleep disorders were carried out. Statistical analysis was carried out using SPSS Statistics (version 20.0, IBM, USA). The results of studies indicate a progressive neurological deterioration in COVID-19 patients. Neuropsychological observations in patients taking a full course of MLT showed an objective improvement in their cognitive, autonomic and sleep disorders. In particular, the Pittsburgh Sleep Quality Index (PSQI), Insomnia Severity Index (ISI), Montreal Cognitive Assessment (MoCA) Scale, Schulte Tables, Spielberger-Khanin Anxiety Scale (SKAS), Beck depression inventory (BDI), Study scheme to identify signs of autonomic disorders, Epworth Sleepiness Scale (ESS), Index of Severity of Sleep Disorders (ISSD) values improved after the MLT procedures.

Keywords

COVID-19, Hirudotherapy, Medicinal Leech Therapy, Cognitive Disorders, Autonomic Disorders, Sleep Disorders

References

• Altena E, Baglioni C, Espie CA, Ellis J, Gavriloff D, Holzinger B, et al. Dealing with sleep problems during home confinement due to the COVID-19 outbreak: Practical recommendations from a task force of the European CBT-I Academy. J Sleep Res. 2020; 29(4), e13052. https://doi.org/10.1111/jsr.13052
• Apfel SC. Neurotrophic factors in peripheral neuropathies: therapeutic implications. Brain Pathol. 1999; 9(2), 393-413. https://doi.org/10.1111/j.1750-3639.1999.tb00234.x
• Budkevich RO, Budkevich EV. Zh Nevrol Psikhiatr Im SS Korsakova. Anxiety, sleep self-assessment, cortisol and saliva antioxidants in students with occasional experience of shift work. 2018;118(4.Vyp.2), 21-25. Russian. https://doi.org/10.17116/jnevro20181184221
• Butcher JN, Taylor J, Cynthia Fekken G. Objective Personality Assessment with Adults. In: Bellack AS, Hersen M (eds) Comprehensive Clinical Psychology. Pergamon, Oxford. 1998: 403-429. https://doi.org/10.1016/B0080-4270(73)00018-3
• Buysse DJ, Reynolds CF, 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989; 28(2), 193-213. https://doi.org/10.1016/0165-1781(89)90047-4
• Chater N, Felin T, Funder DC, Gigerenzer G, Koenderink JJ, Krueger JI, et al.Mind, rationality, and cognition: An interdisciplinary debate. Psychon Bull Rev. 2018; 25(2), 793-826. https://doi.org/10.3758/s13423-017-1333-5
• Conforti ML, Connor NP, Heisey DM, Hartig GK. Evaluation of Performance Characteristics of the Medicinal Leech (Hirudomedicinalis) for the Treatment of Venous Congestion. Plast Reconstr Surg. 2002;109(1).
• Furie KL, Cushman M, Elkind MSV, Lyden PD, Saposnik G, American Heart Association/American Stroke Association Stroke Council Leadership Stroke. Diagnosis and Management of Cerebral Venous Sinus Thrombosis with Vaccine-Induced Immune Thrombotic Thrombocytopenia. Stroke. 2021; 52(7), 2478. https://doi.org/10.1161/STROKEAHA.121.035564
• Giglia TM, Massicotte MP, Tweddell JS, Barst RJ, Bauman M, Erickson CC, et al. Prevention and Treatment of Thrombosis in Pediatric and Congenital Heart Disease. Circulation. 2013; 128(24), 2622-2703. https://doi.org/10.1161/01.cir.0000436140.77832.7a
• Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18), 1708-1720. https://doi.org/10.1056/NEJMoa2002032
• Guerrero JI, Barragán LA, Martínez JD, Montoya JP, Peña A, Sobrino FE, et al.Central and peripheral nervous system involvement by COVID-19: a systematic review of the pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings. BMC Infec Dis. 2021; 21(1), 515. https://doi.org/10.1186/s12879-021-06185-6
• Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991; 14(6), 540-545. https://doi.org/10.1093/sleep/14.6.540
• Koeppen D, Aurich M, Pasalar M, Rampp T. Medicinal leech therapy in venous congestion and various ulcer forms: Perspectives of Western, Persian and Indian medicine. J Tradit Complement Med. 2020; 10(2),104-109. https://doi.org/10.1016/j.jtcme.2019.08.003
• Korchounov A, Kessler KR, Yakhno NN, Damulin IV, Schipper HI. Determinants of autonomic dysfunction in idiopathic Parkinson’s disease. J Neurol. 2005; 252(12), 1530-1536. https://doi.org/10.1007/s00415-005-0909-6
• Kotfis K, Williams Roberson S, Wilson JE, Dabrowski W, Pun BT, Ely EW. COVID-19: ICU delirium management during SARS-CoV-2 pandemic. Crit Care. 2020; 24(1), 176. https://doi.org/10.1186/s13054-020-02882-x
• Kulbida R, Mathes A, Loeser J. Beneficial effects of hirudotherapy in a chronic case of complex regional pain syndrome. J Integr Med. 2019; 17(5), 383-386. https://doi.org/10.1016/j.joim.2019.05.005
• Kumar S, Veldhuis A, Malhotra T. Neuropsychiatric and Cognitive Sequelae of COVID-19. Front Psychol. 2021; 12,553.
• Le Marrec-Croq F, Drago F, Vizioli J, Sautière P-E, Lefebvre C. The Leech Nervous System: A Valuable Model to Study the Microglia Involvement in Regenerative Processes. Clin Dev Immunol. 2013; 274019. https://doi.org/10.1155/2013/274019
• Lemke S, Vilcinskas A. European Medicinal Leeches-New Roles in Modern Medicine. Biomedicines. 2020; 8(5), 99. https://doi.org/10.3390/biomedicines8050099
• Mahendran R, Chua J, Feng L, Kua EH, Preedy VR. Chapter 109 - The Mini-Mental State Examination and Other Neuropsychological Assessment Tools for Detecting Cognitive Decline. In: Martin CR, Preedy VR (eds) Diet and Nutrition in Dementia and Cognitive Decline. Academic Press, San Diego. 2015:1159-1174. https://doi.org/10.1016/B978-0-12-407824-6.00109-9
• Manzar MD, Salahuddin M, Alamri M, Albougami A, Khan MYA, Nureye D, et al. Psychometric properties of the Epworth sleepiness scale in Ethiopian university students. Health Qual Life Outcomes. 2019; 17(1), 30. https://doi.org/10.1186/s12955-019-1098-9
• Meier IB, Vieira Ligo Teixeira C, Tarnanas I, Mirza F, Rajendran L. Neurological and mental health consequences of COVID-19: potential implications for well-being and labour force. Brain Commun. 2021; 3(1). https://doi.org/10.1093/braincomms/fcab012
• Moosavian HR, Mirghazanfari SM, Moghaddam KG. Effect of Ischemia Preconditioning and Leech Therapy on Cutaneous Pedicle Flaps Subjected to Prolonged Ischemia in a Mouse Model. Aesthetic Plast Surg. 2014; 38(5), 1024-1029. https://doi.org/10.1007/s00266-014-0399-y
• Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020; 94, 55-58. https://doi.org/10.1016/j.ijid.2020.03.062
• Morin CM, Belleville G, Bélanger L, Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011; 34(5), 601-608. https://doi.org/10.1093/sleep/34.5.601
• Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005; 53(4), 695-699. https://doi.org/10.1111/j.1532-5415.2005.53221.x
• Partinen M. Sleep research in 2020: COVID-19-related sleep disorders. The Lancet Neurology. 2021; 20(1), 15-17. https://doi.org/10.1016/S1474-4422(20)30456-7
• Paterson RW, Brown RL, Benjamin L, Nortley R, Wiethoff S, Bharucha T, et al. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. 2020; 143(10), 3104-3120. https://doi.org/10.1093/brain/awaa240
• Pensato U, Muccioli L, Cani I, Janigro D, Zinzani PL, Guarino M, et al.Brain dysfunction in COVID-19 and CAR-T therapy: cytokine storm-associated encephalopathy. Ann Clin Transl Neurol. 2021; 8(4), 968-979. https://doi.org/10.1002/acn3.51348
• Pilz LK, Keller LK, Lenssen D, Roenneberg T. Time to rethink sleep quality: PSQI scores reflect sleep quality on workdays. Sleep. 2018; 41(5). https://doi.org/10.1093/sleep/zsy029
• Rakhmatullin AR, Bakhtiiarova KZ, Magzhanov RV. Zh Nevrol PsikhiatrIm SS Korsakova. Autonomic dysfunction in patients with multiple sclerosis. 2017; 117(1), 55-58. Russian. https://doi.org/10.17116/jnevro20171171155-58
• Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020; 109, 102433. https://doi.org/10.1016/j.jaut.2020.102433
• Sánchez-de-la-Torre M, Sánchez-de-la-Torre A, Bertran S, Abad J, Duran-Cantolla J, Cabriada V, et al. Effect of obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular events in patients with acute coronary syndrome (ISAACC study): a randomised controlled trial. Lancet Respir Med. 2020; 8(4), 359-367. https://doi.org/10.1016/s2213-2600(19)30271-1
• Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008; 4(5), 487-504.
• Serikbaeva S. ZH. Osnova hirudotherapy. Shymkent Printing House "Alem". 2022.
• Shouman K, Vanichkachorn G, Cheshire WP, Suarez MD, Shelly S, Lamotte GJ, et al. Autonomic dysfunction following COVID-19 infection: an early experience. Clin Auton Res. 2021; 31(3), 385-394. https://doi.org/10.1007/s10286-021-00803-8
• Sig AK, Guney M, Uskudar Guclu A, Ozmen E. Medicinal leech therapy-an overall perspective. Integr Med Res. 2017; 6(4), 337-343. https://doi.org/10.1016/j.imr.2017.08.001
• Snyder E, Cai B, DeMuro C, Morrison MF, Ball W. A New Single-Item Sleep Quality Scale: Results of Psychometric Evaluation in Patients with Chronic Primary Insomnia and Depression. J Clin Sleep Med. 2018; 14(11), 1849-1857. https://doi.org/10.5664/jcsm.7478
• Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. The Lancet Psychiatry. 2021; 8(5), 416-427. https://doi.org/10.1016/S2215-0366(21)00084-5
• Varatharaj A, Thomas N, Ellul MA, Davies NWS, Pollak TA, Tenorio EL, et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. The Lancet Psychiatry. 2020; 7(10), 875-882. https://doi.org/10.1016/S2215-0366(20)30287-X
• Woo EJ, Mba-Jonas A, Dimova RB, Alimchandani M, Zinderman CE, Nair N. Association of Receipt of the Ad26.COV2. S COVID-19 Vaccine with Presumptive Guillain-Barré Syndrome, February-July 2021. JAMA. 2021; 326(16), 1606. https://doi.org/10.1001/jama.2021